France’s first reported human Shamonda virus infection raises questions about transmission and vulnerable patients. Explore what investigators know, what remains uncertain, and why infection preventionists should follow this emerging story.
Feature|Slideshows|February 26, 2026
CDC Vaccine Schedule Update Sparks Concern Among Infection Prevention Professionals, Survey Finds Communication and Confidence Gaps
Author(s)Tori Whitacre Martonicz, MA
Infection prevention professionals are weighing in on the CDC’s updated vaccine schedule. An ICT survey reveals mixed familiarity, rising patient questions, and a strong call for clearer guidance and communication tools. Here’s what IPC leaders say about implementation, confidence, and the real-world impact of vaccine policy changes.
Advertisement
Advertisement
When the CDC released its updated vaccine schedule, Infection Control Today® (ICT®) conducted a survey to understand how infection prevention and control (IPC) professionals are interpreting the change and how it is affecting operations on the ground. The results reveal a community that is engaged, thoughtful, and seeking clarity. Many are also deeply unsettled.
Related to this article
Kenya’s secondary Ebola cases raise urgent questions about hospital readiness. Explore what the response reveals about contact tracing, health care worker protection, and the implementation of infection prevention plans.
Presented at IDWeek 2026, a living review of 64 studies found the strongest evidence for dengue prevention from mosquito modification, while highlighting substantial uncertainty and research gaps in other approaches to Aedes vector control.
A poster presented at IDWeek was a systematic review of 35 studies that found rare transmission of viral hemorrhagic fever to health care personnel in high-income countries and highlighted the need for standardized exposure definitions to guide response.
A proposed hepatitis B vaccine trial in Guinea-Bissau raises concerns about delaying newborn protection. This commentary examines the ethical obligations of researchers and the consequences of weakening established prevention efforts.
An unexplained death at a Russian plague research institute has prompted international scrutiny. The incident raises questions about laboratory safety, transparent reporting, and infection prevention preparedness while the cause remains unconfirmed.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
What might infection prevention rounds miss when visible conditions dominate the conversation? Tommy Davis, PhD, CMIP, a member of ICT's executive advisory board, makes the case for structured observations of clinical workflows, shared accountability, and greater attention to environmental services staff’s insights.
Advertisement
Advertisement